Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.verified

4521.T

Price:

$4020

Market Cap:

$152.23B

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatm...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2001-01-01

Stock Exchange

JPX

Ticker

4521.T

The PE Ratio as of December 2025 (TTM) for Kaken Pharmaceutical Co., Ltd. (4521.T) is 277.82

According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 277.82. This represents a change of 509.23% compared to the average of 45.60 of the last 4 quarters.

Kaken Pharmaceutical Co., Ltd. (4521.T) Historical PE Ratio (quarterly & annually)

How has 4521.T PE Ratio performed in the past?

The mean historical PE Ratio of Kaken Pharmaceutical Co., Ltd. over the last ten years is 14.21. The current 277.82 PE Ratio has changed 195.39% with respect to the historical average. Over the past ten years (40 quarters), 4521.T's PE Ratio was at its highest in in the June 2025 quarter at 134.06. The PE Ratio was at its lowest in in the March 2022 quarter at -52.77.

Quarterly (TTM)
Annual

Average

14.21

Median

12.91

Minimum

10.16

Maximum

25.52

Kaken Pharmaceutical Co., Ltd. (4521.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 64.95%

Maximum Annual PE Ratio = 25.52

Minimum Annual Increase = -44.25%

Minimum Annual PE Ratio = 10.16

Quarterly (TTM)
Annual
YearPE RatioChange
202512.26-24.78%
202416.30-36.11%
202325.5264.95%
202215.4723.97%
202112.4822.78%
202010.16-11.68%
201911.51-13.77%
201813.3513.88%
201711.72-12.14%
201613.34-44.25%

Kaken Pharmaceutical Co., Ltd. (4521.T) Average PE Ratio

How has 4521.T PE Ratio performed in the past?

The current PE Ratio of Kaken Pharmaceutical Co., Ltd. (4521.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

18.03

5-year avg

16.41

10-year avg

14.21

Kaken Pharmaceutical Co., Ltd. (4521.T) PE Ratio vs. Peers

How is 4521.T’s PE Ratio compared to its peers?

Kaken Pharmaceutical Co., Ltd.’s PE Ratio is greater than Towa Pharmaceutical Co., Ltd. (8.74), greater than Kissei Pharmaceutical Co., Ltd. (13.18), greater than BML, Inc. (20.97), greater than Mochida Pharmaceutical Co., Ltd. (18.05), greater than Zeria Pharmaceutical Co., Ltd. (16.35), greater than PHC Holdings Corporation (24.30), greater than KYORIN Holdings, Inc. (9.35), greater than Mani, Inc. (26.96), greater than GNI Group Ltd. (-157.45), greater than Tsuruha Holdings Inc. (24.27),

Build a custom stock screener for Kaken Pharmaceutical Co., Ltd. (4521.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kaken Pharmaceutical Co., Ltd. (4521.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kaken Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Kaken Pharmaceutical Co., Ltd. (4521.T)?

What is the highest PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?

What is the 3-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?

What is the 5-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?

How does the current PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T) compare to its historical average?